Herndon, VA. (April 6, 2022) — Constellis, a leading provider of essential risk management and mission support services to government and commercial customers worldwide, announced today that the company’s Triple Canopy entity was awarded the Counterdrug (CD) Operations, Maintenance, Engineering and Analysis Support Services Task Order under OASIS. This firm-fixed price win is the company’s first under the OASIS Indefinite Delivery Indefinite Quantity (IDIQ) contract.
Under this Task Order, Triple Canopy will continue to support efforts associated with ACC’s CD program. These tasks involve operations and maintenance services on CD surveillance and communications systems, including radars, commercial satellite systems and radio systems.
“We are honored that ACC selected Triple Canopy to continue supporting this important mission under OASIS,” said James Noe, President, Global Support Operations for Constellis. “We are focused on a seamless transition and continuing to provide critical support to CD surveillance and communications systems.”
“We are committed to the CD mission across many federal activities.” said Terry Ryan, Chief Executive Officer of Constellis. “We are leveraging OASIS and other prime federal IDIQ contracts to provide specialized operational and technical support services to meet growing demands across all CD mission areas.”
About Constellis
In an ever-changing and complex world, security concerns are paramount. Enhanced security requires education, training and specialized skills. Constellis provides end-to-end risk management and comprehensive security solutions to safeguard people and infrastructure globally. Our team of strategic problem solvers has a steadfast moral compass and unwavering dedication to creating a safer world. Constellis is committed to the success of our customers and partners.
Headquartered in the Washington, DC, area, Constellis has operated in over 50 countries and across five continents.
Learn more about us at Constellis.com, and follow us on LinkedIn, Facebook and Twitter.
# # #
For more information, please contact:
+1 866 996 3599
We use cookies on this website to improve functionality and performance, to analyze traffic, and to enable social media features. To learn more, please see our Privacy Policy.